These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 26519843

  • 1. Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis.
    Zajkowska A, Garkowski A, Czupryna P, Moniuszko A, Król ME, Szamatowicz J, Pancewicz S.
    Przegl Epidemiol; 2015; 69(3):479-82, 597-600. PubMed ID: 26519843
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of complications during pregnancy in women with serological features of acute toxoplasmosis or acute parvovirosis].
    Marcinek P, Nowakowska D, Szaflik K, Spiewak E, Małafiej E, Wilczyński J.
    Ginekol Pol; 2008 Mar; 79(3):186-91. PubMed ID: 18592853
    [Abstract] [Full Text] [Related]

  • 3. [NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].
    Voleva S, Ivanova S, Marinov B, Genova-Kalou P, Manolov V, Vasilev V.
    Akush Ginekol (Sofiia); 2016 Mar; 55(3):30-9. PubMed ID: 27514136
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin.
    De Paschale M, Ceriani C, Cerulli T, Cagnin D, Cavallari S, Zaongo D, Diombo K, Priuli G, Viganò P, Finazzi S, Clerici P.
    Trop Med Int Health; 2023 Mar; 28(3):226-231. PubMed ID: 36647788
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
    Rezaei F, Sarshari B, Ghavami N, Meysami P, Shadab A, Salimi H, Mokhtari-Azad T.
    J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
    Wang Y, Hedman L, Nurmi V, Ziemele I, Perdomo MF, Söderlund-Venermo M, Hedman K.
    mSphere; 2020 Mar 18; 5(2):. PubMed ID: 32188754
    [Abstract] [Full Text] [Related]

  • 17. Detection of Toxoplasma gondii B1 Gene and IgM in IgG Seropositive Pregnant Women.
    Sardarian K, Maghsood AH, Farimani M, Hajilooi M, Saidijam M, Ghane ZZ, Mahaki H, Zamani A.
    Clin Lab; 2019 Jan 01; 65(1):. PubMed ID: 30775900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
    Weseslindtner L, Aberle JH, Hedman L, Hedman K.
    J Infect Dis; 2017 Jan 15; 215(2):214-220. PubMed ID: 27789725
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.